Improvements in clinical signs of Parkinsons using Photobiomodulation
Improvements in clinical signs of Parkinson’s disease using photobiomodulation: A prospective proof-of-concept study
Background:
Parkinson’s disease (PD) is a progressive neurodegenerative disease with no cure and few treatment options. Its incidence is increasing due to aging populations, longer disease duration and potentially as a COVID-19 sequela. Photobiomodulation (PBM) has been successfully used in animal models to reduce the signs of PD and to protect dopaminergic neurons.
